A 38-year-old woman with acute asthma exacerbation is treated with salbutamol nebulization. After 20 minutes, her peak expiratory flow improves from 180 L/min to 280 L/min, but she remains dyspneic with an oxygen saturation of 88% on room air. Respiratory rate is 26/min. What is the most appropriate next step in management?

Question

Accepted Answer

C. Repeat salbutamol nebulization and add supplemental oxygen. ## Clinical Context
This patient has had a **partial response** to initial salbutamol nebulization — peak flow improved from 180 to 280 L/min, but she remains dyspneic, tachypneic (RR 26/min), and hypoxic (SpO₂ 88%). This is an acute, life-threatening situation requiring immediate concurrent interventions.

## Why Option A is the Most Appropriate Next Step
**Key Point:** In acute asthma with partial SABA response and ongoing hypoxemia, the **immediate** priorities are:
1. **Correct hypoxemia** — SpO₂ of 88% is dangerous and must be addressed within minutes. Supplemental oxygen (target SpO₂ 93–95% per GINA) is a first-line emergency measure.
2. **Repeat bronchodilator** — Salbutamol nebulization should be repeated (every 20 minutes in the first hour, or continuously) as the patient has not achieved adequate bronchodilation. GINA and BTS guidelines recommend repeated/continuous SABA as the cornerstone of acute exacerbation management.

These two interventions (repeat SABA + supplemental O₂) are the most immediate, direct, and life-saving steps and should occur **before or simultaneously with** systemic corticosteroids.

## Role of Systemic Corticosteroids
Systemic corticosteroids (Option D) are absolutely indicated in this scenario and should be initiated early — but their onset of action is 4–6 hours (genomic mechanism). They do **not** address the immediate hypoxemia or bronchospasm in the next few minutes. In standard acute asthma protocols (GINA 2023, BTS/SIGN), repeat SABA + oxygen is the first action, with corticosteroids added as a concurrent but slightly downstream step.

**High-Yield:** The "next step" framing in this vignette — with SpO₂ 88% and ongoing dyspnea — demands the most immediate life-saving intervention, which is correcting hypoxemia and repeating bronchodilation, not waiting for corticosteroids to take effect.

## Why Other Options Are Wrong
- **Option B (Salmeterol):** Long-acting beta-2 agonists are contraindicated as monotherapy in acute exacerbations. Onset is too slow (12–24 hours) and they do not provide rapid bronchodilation. (KD Tripathi, Essentials of Medical Pharmacology, 8th ed.)
- **Option C (IV Magnesium Sulfate):** Reserved for severe/life-threatening asthma not responding to initial bronchodilator therapy (typically after 3 doses of SABA + ipratropium + steroids). Not the next step here.
- **Option D (Systemic Corticosteroids):** Important and should be given early, but does not address the immediate hypoxemia or acute bronchospasm. Repeat SABA + O₂ takes precedence as the most immediate intervention.

## Clinical Pearl
**GINA 2023 Acute Asthma Protocol:** Step 1 — Supplemental O₂ + repeated SABA (salbutamol) every 20 minutes. Step 2 — Add systemic corticosteroids early. Step 3 — Add ipratropium bromide. Step 4 — Consider IV magnesium sulfate for severe cases. The sequence matters: oxygen and repeat SABA are the first actions in a patient with SpO₂ 88%.

*Reference: GINA Global Strategy for Asthma Management 2023; BTS/SIGN British Guideline on the Management of Asthma 2022; KD Tripathi Essentials of Medical Pharmacology 8th ed.*

![Pharmacodynamics and Receptor Theory diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/3634.webp)

Answer

A. Switch to a long-acting beta-2 agonist (salmeterol)

Answer

B. Initiate systemic corticosteroids (oral or intravenous)

Answer

D. Administer intravenous magnesium sulfate

Explanation

Clinical Context

Why Option A is the Most Appropriate Next Step

Role of Systemic Corticosteroids

Why Other Options Are Wrong

Clinical Pearl

Practice similar questions

Join our NEET PG community